Ann: Change in Director's Interest Notice - Cheryl Maley, page-12

Good to see the CEO and Chairman dip their hands into deep pockets and buy shares on market

Starpharma Holdings Limited has announced a change in the interests of Director Cheryl Maley, who has acquired 125,000 ordinary shares on-market, with the transaction valued at approximately $0.115 per share. Post-acquisition, Maley’s direct interest in the company includes these shares along with 2,278,428 performance rights.



Starpharma Holdings Limited has reported a change in Director Robert B. Thomas's interests, where Thomas, through indirect ownership, acquired an additional 150,000 ordinary shares on the market, bringing his total to 1,450,000 shares. The purchase was made for personal use at prices ranging from $0.115 to $0.12 per share, with no disposal of shares reported.